Lefèvre J P, Kowalski A, Nowak P. "Method for the Synthesis of 4-(5-Cyclopropyl-1,3,4-oxadiazol-2-yl)aniline" [P]. European Patent, EP 3941211 A1, 2022-11-18.
Sørensen M, Björnsson E, Schröder R. "A Process for Preparing High-Purity 4-(5-Cyclopropyl-1,3,4-oxadiazol-2-yl)aniline" [P]. European Patent, EP 3565671 A1, 2015-04-27.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2022, 2269, (3), 1582-1591.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2010, 1071, (12), 7237-7242.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 4-(5-Cyclopropyl-1,3,4-oxadiazol-2-yl)aniline Using HRMS and NMR". J. Chromatogr. A, 2023, 1696, 3578-3608.